One in every three deaths in America is due to heart disease or stroke—equivalent to 2,200 deaths every day. Heart disease is also expensive—over $400 billion dollars a year in healthcare costs and lost productivity. High blood pressure, oxidized LDL cholesterol and atherosclerosis (hardening of the arteries), chronic inflammation, and even other diseases such as diabetes and abnormal thyroid levels are associated with developing heart disease. Experts have estimated that if we were to eliminate heart disease, we’d add about 10 years to the average human lifespan.

Many factors figure into heart and blood vessel disease, including strokes, but one thing they have in common is the strength of the blood vessel wall, and the need for uninterrupted, healthy blood circulation. There are no drugs to make the blood vessels stronger, but there is an amazingly powerful building block nutrient called mesoglycan.

Mesoglycan is an excellent source of glycosaminoglycans, or GAGs—vital and necessary components that build the walls of blood vessels and arteries.

Mesoglycan has been shown to prevent or slow atherosclerosis as well as to treat other diseases of the veins and arteries, including chronic venous insufficiency and diabetic retinopathy. Mesoglycan has more than one mechanism of action: it works on the actual formation of blood vessel walls, helping them to be strong, yet flexible, plus it helps keep blood moving through the arteries and blood vessels.

Strengthens Arteries, Prevents Abnormal Clotting, Promotes Blood Flow
Blood clots form a protein called fibrin. Mesoglycan, aside from helping build the structure of blood vessels and arteries, also shows fibrinolytic activity. That is, it inhibits the effects of fibrinogen—a marker of inflammation and a precursor to fibrin and abnormal blood-clots—both of which can contribute to heart attack or stroke.

It’s important to note that while mesoglycan helps prevent abnormal blood clots, it does not thin the blood—it appears to improve the fluid properties of red blood cells. This may be due to changes in red cell membrane permeability and cell surface electric charges, or other interactions between the glycan and red membranes.

A clinical study of 18 patients with heart disease (either general atherosclerosis or from diabetes). In a nine-day trial, mesoglycan showed healthy anti-clotting activity after just one dose. Repeated administration showed similar effects, so it was an ongoing benefit.

Another similar clinical trial involving patients dealing with atherosclerotic disease (general or with non-insulin dependent diabetes) showed an improvement in blood flow after just 30 days.

Prevents and Treats Stroke
In clinical studies, mesoglycan has also been shown to help vessel walls remain flexible, as well as to decrease plasma fibrinogen (again, reducing the risk of abnormal clotting) in patients who had previously suffered a stroke.

In fact, in one case, 40 individuals who had a transitory ischemic cerebral attack (TIA), a temporary stoppage of blood often called a “mini-stroke”, were treated with mesoglycan for two years. Aside from four people who had a relapse, the overall effect was very positive. Transitory or transient ischemic attacks are considered a warning, and point to potentially debilitating or fatal problems in the future. The fact that mesoglycan was able to stop the recurrence of these clots provides real hope for patients at risk.

For those who have suffered from a stroke, mesoglycan can help recovery because of the way it strengthens blood vessels in the brain. In an open trial, mesoglycan improved mood, autonomy, memory and emotional lability—the sharp, extreme changes in mood or emotional responses which may or may not be related to the mood at hand—in those with a history of stroke.

Stops Chronic Venous Insufficiency (CVI)
Mesoglycan also strengthens veins in the legs and relieves symptoms of chronic venous insufficiency (CVI), stops venous ulcers and helps prevent the potentially damaging and dangerous clotting due to deep vein thrombosis (DVT). Clinical tests showed that mesoglycan stopped the recurrence of DVT, relieved pain and bruising, and improved overall mobility of those with CVI.

Another clinical study examined the effects of mesoglycan on patients with intermittent claudication who had experienced difficulty and pain from walking due to the narrowing and stiffening of the blood vessels in their legs. By the end of the study, those in the mesoglycan group had fewer ischemic events and better walking distance than the placebo group.

Mesoglycan can be an excellent natural medicine to be used in conjunction with conventional treatment, including compression stockings and other wound care. It has been clinically shown to help heal leg ulcers in just 90 days. In fact, in the mesoglycan group, the leg sores were resolved in 75 percent of the individuals in that time. It took 136 days for the placebo group to get the same results—using only conventional care.

Protects Eyesight, Repairs Retinopathy
In a double-blind, placebo-controlled study of patients suffering diabetic retinopathy, mesoglycan significantly reduced vision-damaging microhemorrhages and micro aneurysms. At the conclusion of the 6-month study, the researchers found that it was very well tolerated, and certainly warranted further study based on these results.

Mesoglycan—A Natural Blood Vessel Builder
The recommend mesoglycan is from a porcine source, so it is a better match to the same building blocks in human bodies. Mesoglycan helps the body strengthen weakened veins, reduce abnormal blood clotting, and promote blood flow. This makes it uniquely recommended for any patient with a history of heart attack, stroke, aneurysm, DVT, or any other circulatory issues.

50-100 mg of mesoglycan daily can help the body strengthen weakened veins, reduce abnormal blood clotting, and promote blood flow.

For more on this topic, watch this webinar >>> Mesoglycan: A Miracle for Varicose Veins, Clot Prevention & More